Halozyme Therapeutics (HALO) PT Lowered to $46 at Piper Sandler

November 7, 2023 7:13 AM EST Send to a Friend
Piper Sandler analyst Joseph Catanzaro ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login